PRL-2 increases Epo and IL-3 responses in hematopoietic cells.

Akiyama, Shoko; Dhavan, Deepika; Yi, Taolin

Akiyama, Shoko; Dhavan, Deepika; Yi, Taolin.

Affiliation

Akiyama S; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Blood Cells Mol Dis ; 44(4): 209-14, 2010 Apr 15.

Article in En | MEDLINE | ID: mdl-20226699

Subject(s)

Erythropoietin/pharmacology; Interleukin-3/pharmacology; Precursor Cells, B-Lymphoid/drug effects; Protein Tyrosine Phosphatases/physiology; Animals; Bone Marrow Cells/cytology; Cell Adhesion/drug effects; Cell Dedifferentiation/drug effects; Cell Division/drug effects; Cell Line/cytology; Cell Line/drug effects; Cell Movement/drug effects; Cell Survival/drug effects; Colony-Forming Units Assay; Epoetin Alfa; Hematologic Neoplasms/etiology; Humans; Mice; Mice, Inbred C57BL; Precursor Cells, B-Lymphoid/cytology; Protein Tyrosine Phosphatases/genetics; Recombinant Fusion Proteins/physiology; Recombinant Proteins; STAT5 Transcription Factor/biosynthesis; STAT5 Transcription Factor/genetics; Transduction, Genetic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Interleukin-3 / Protein Tyrosine Phosphatases / Precursor Cells, B-Lymphoid Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google